Publikationen, an denen er mitarbeitet Juan Carlos Hernández Boluda (2)

2024

  1. e14a2 Transcript Favors Treatment-Free Remission in Chronic Myeloid Leukemia When Associated with Longer Treatment with Tyrosine Kinase Inhibitors and Sustained Deep Molecular Response

    Journal of Clinical Medicine, Vol. 13, Núm. 3

2021

  1. Impact of bcr-abl1 transcript type on response, treatment-free remission rate and survival in chronic myeloid leukemia patients treated with imatinib

    Journal of Clinical Medicine, Vol. 10, Núm. 14